Treatment Preferences in Patients With Hypothyroidism
Authors:
- Giulia CarvalhalGCGiulia Carvalhal
- Daniele Carvalhal de Almeida BeltrãoDBDaniele Carvalhal de Almeida Beltrão
- Fabricia Elizabeth de Lima BeltrãoFBFabricia Elizabeth de Lima Beltrão
- Miriam O RibeiroMRMiriam O Ribeiro
- Matthew D EttlesonMEMatthew D Ettleson
- Helton Estrela RamosHRHelton Estrela Ramos
- Antonio C BiancoABAntonio C Bianco
- 18 September 2024
- journal article
- research article
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 110 (3) , 887-900
Abstract
Context: Levothyroxine (L-T4) monotherapy is the standard of care for the treatment of hypothyroidism. A minority of L-T4–treated patients remain symptomatic and report better outcomes with combination therapy that contains liothyronine (L-T3) or with desiccated thyroid extract (DTE). Objective: This work aimed to assess patient preferences in the treatment of hypothyroidism. Methods: A systematic review, meta-analysis, meta-regression, and network meta-analysis of randomized controlled trials (RCTs) comparing treatments for adults with hypothyroidism (L-T4 vs L-T4 + L-T3 or DTE). Searches were conducted in PubMed, Embase, and Cochrane databases up to April 10, 2024. Data extraction and quality assessment were independently performed by 4 researchers. Results: Eleven RCTs (8 cross-over studies) with a total of 1135 patients were considered. Overall, 24% of patients preferred L-T4 vs 52% who preferred L-T4 + L-T3 or DTE; 24% had no preference. The meta-analysis confirmed the preference for combination therapy over L-T4 monotherapy (relative risk [RR]: 2.20; 95% CI, 1.38-3.52; P = .0009). Excluding 4 studies reduced the high heterogeneity (I2 = 81%) without affecting the results (RR: 1.97; 95% CI, 1.52-2.54; P < .00001; I2 = 24%). This preference profile remained when only crossover studies were considered (RR: 2.84; 95% CI, 1.50-5.39; P < .00001). Network meta-analysis confirmed the preference for DTE and L-T3 + L-T4 vs L-T4 alone. Conclusion: Patients with hypothyroidism prefer combination therapy (L-T3 + L-T4 or DTE) over L-T4 monotherapy. The strength of these findings justifies considering patient preferences in the setting of shared decision-making in the treatment of hypothyroidism.Keywords
Funding Information
- National Institute of Diabetes and Digestive and Kidney Diseases (DK58538, DK65066, DK77148)
- University of Chicago (DK020595)
- Fundação à Pesquisa do Estado de São Paulo (FAPESP 2021/12746-3, PROEX No. 2017/2023 88881.910035/2023-01)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico ((No. 403066/2022-0)
This publication has 45 references indexed in Scilit:
- Primary hypothyroidism and quality of lifeNature Reviews Endocrinology, 2022
- Brain Fog in Hypothyroidism: Understanding the Patient’s PerspectiveEndocrine Practice, 2021
- Hyperactive behavioral phenotypes and an altered brain monoaminergic state in male offspring mice with perinatal hypothyroidismToxicology Reports, 2019
- Empirical Comparison of Publication Bias Tests in Meta-AnalysisJournal of General Internal Medicine, 2018
- Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorialJournal of Clinical Epidemiology, 2011
- Analysing Data and Undertaking Meta‐Analyses2008
- Identification of a Mammalian Homologue of the Fungal Tom70 Mitochondrial Precursor Protein Import Receptor as a Thyroid Mitochondrial Precursor Protein Import Receptor as a Thyroid Hormone‐Regulated Gene in Specific Brain RegionsJournal of Neurochemistry, 1999
- Effects of Thyroxine as Compared with Thyroxine plus Triiodothyronine in Patients with HypothyroidismNew England Journal of Medicine, 1999
- THYROID EXTRACTThe Lancet, 1961
- WHY DOES ANYBODY USE THYROID B.P. ?The Lancet, 1961